Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
Medication major Dr Reddy’s Laboratories on Friday said the US wellbeing controller has shut assessment of its assembling office in Srikakulam, Andhra Pradesh.
The US Food and Drug Administration (USFDA) had given an admonition letter to the office in November, 2015, in the wake of assessing it in 2014.
“We have gotten the foundation examination report from the USFDA, for the Srikakulam office, demonstrating conclusion of the review and the investigation characterization of this office,” Dr Reddy’s Laboratories said in an administrative documenting.
With this, all offices under notice letter are presently decided as ‘intentional activity showed’, the medication major said.
